Fresenius reported EUR823M in Selling and Administration Expenses for its fiscal quarter ending in September of 2026.





Selling And Administration Expenses Change Date
Akzo Nobel EUR 816M 17M Sep/2026
Alcon AG USD 929M 35M Sep/2026
AstraZeneca USD 4.07B 1.73B Sep/2026
BASF EUR 2.16B 123M Sep/2026
Bayer EUR 4.02B 53M Sep/2026
Beiersdorf EUR 282M 11M Jun/2026
DaVita Healthcare Partners USD 423.46M 1.54M Jun/2026
Demant DKK 7.09B 1B Jun/2026
E.ON EUR -1.71B 3.63B Jun/2025
Essilor EUR 5.75B 139M Jun/2026
Fresenius EUR 823M 63M Sep/2026
Fresenius Medical Care EUR 744M 7.99M Sep/2026
Getinge SEK 2.65B 452M Dec/2024
Givaudan CHF 561M 25M Dec/2025
GlaxoSmithKline GBP 2.16B 39M Sep/2026
GN Store Nord DKK 751M 54M Sep/2026
GRIFOLS EUR 326M 37M Sep/2026
Hikma Pharmaceutical USD 288M 149M Dec/2025
Merck EUR 1.58B 11M Sep/2026
Novartis USD 3.08B 163M Sep/2026
Philips EUR 1.17B 33M Sep/2026
Roche Holding CHF 6.37B 908M Jun/2026
RWE EUR 690M 84M Mar/2025
Sanofi EUR 2.31B 325M Sep/2026
Smith & Nephew USD 1.45B 29M Jun/2026